Nalls Sherbakoff Group’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$351 Hold
18
﹤0.01% 364
2026
Q1
$346 Hold
18
﹤0.01% 397
2025
Q4
$341 Hold
18
﹤0.01% 428
2025
Q3
$336 Hold
18
﹤0.01% 414
2025
Q2
$332 Hold
18
﹤0.01% 416
2025
Q1
$314 Buy
+18
New +$303 ﹤0.01% 422
2023
Q4
$257 Hold
18
﹤0.01% 439
2023
Q3
$251 Hold
18
﹤0.01% 446
2023
Q2
$203 Hold
18
﹤0.01% 470
2023
Q1
$204 Buy
+18
New +$223 ﹤0.01% 505
2018
Q4
$0 Buy
+18
New +$362 ﹤0.01% 399

Other funds holding SBRA

Nalls Sherbakoff Group's SBRA Position: Q2 2026 in Review

Nalls Sherbakoff Group held its Sabra Healthcare REIT (SBRA) position steady in Q2 2026 at 18 shares worth $351. The position accounts for ﹤0.01% of the portfolio, ranked #364.

Nalls Sherbakoff Group first reported a position in SBRA in Q4 2018 and has held it in 11 quarters since. 463 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Nalls Sherbakoff Group held 18 shares of Sabra Healthcare REIT worth $351 as of Q2 2026.
  • Nalls Sherbakoff Group left its Sabra Healthcare REIT share count unchanged in Q2 2026.
  • Sabra Healthcare REIT made up ﹤0.01% of Nalls Sherbakoff Group's portfolio in Q2 2026, its #364 holding.
  • Nalls Sherbakoff Group first reported a position in Sabra Healthcare REIT in Q4 2018 and has held it in 11 quarters since.
  • 463 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Nalls Sherbakoff Group's 13F filing for Q2 2026, filed 17 Aug 2026.